Reply to: “Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure”

Yousif, Walid Ibrahim

doi:10.1016/j.dld.2021.06.014

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…of COVID-19 patients (Cai et al, 2020;Metawea et al, 2021;Nasa and Alexander, 2021;Yousif, 2021). However, little is known about the histopathological features of the liver during infection.…”

Section: Introductionmentioning

confidence: 99%

Potential histopathological and immunological effects of SARS-CoV-2 on the liver

Alnamshan

2022

Braz. J. Biol.

View full text Add to dashboard Cite

The coronavirus disease outbreak of 2019 (COVID-19) poses a serious threat to public health worldwide. Lung injury is the most common complication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. However, other organs, including the liver, can also be affected. Currently, there is limited evidence that liver impairment is associated with severe SARS-CoV-2 infection. Clinicians will need to determine whether liver injury is caused by an underlying liver condition, COVID-19 therapy, the virus directly, or immune-mediated inflammation or represents a complicated disease course in the context of COVID-19. To address the scarcity of data on histopathological changes and immunological effects on the liver with COVID-19 positivity, we analyze and summarize recent findings. We searched PubMed, Medline, Google Scholar, Science Direct, Scopus, and Web of Science databases up to December 1, 2021, identifying published studies with the search terms “Histopathology in COVID-19,” “COVID-19,” “Pathological changes in liver in COVID-19,” “Liver pathology in COVID-19,” “immunological effects in liver in COVID-19,” and “SARS-CoV-2.” This concise review will aid clinicians and researchers in better understanding the tissue histopathology and immunological consequences of SARS-CoV-2 on the liver, enabling improved care planning and avoiding future dangers.

show abstract

Section: Introductionmentioning

confidence: 99%

Potential histopathological and immunological effects of SARS-CoV-2 on the liver

Alnamshan

2022

Braz. J. Biol.

View full text Add to dashboard Cite

show abstract

Reply to: “Characteristics and in-hospital outcomes of COVID-19 patients with acute or subacute liver failure”

Cited by 1 publication

References 6 publications

Potential histopathological and immunological effects of SARS-CoV-2 on the liver

Potential histopathological and immunological effects of SARS-CoV-2 on the liver

Contact Info

Product

Resources

About